Patent: 8,956,625
✉ Email this page to a colleague
Summary for Patent: 8,956,625
| Title: | Inactivated polio vaccines |
| Abstract: | The present invention relates to the field of vaccines for protecting against polio, and in particular to combination vaccines for protecting against polio, diphtheria, tetanus, and pertussis diseases. Specifically, vaccines comprising reduced dose inactivated poliovirus are provided. |
| Inventor(s): | De Hemptinne Herve, Duchene Michel, Mary Anne, Sonveaux Marc |
| Assignee: | GlaxoSmithKline Biologicals, S.A. |
| Application Number: | US12440043 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,956,625
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Sanofi Pasteur Inc. | N/A | tetanus toxoid adsorbed | Injection | 103913 | December 09, 1999 | 8,956,625 | 2027-09-07 |
| Glaxosmithkline Biologicals | KINRIX | diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine | Injection | 125260 | June 24, 2008 | 8,956,625 | 2027-09-07 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 8,956,625
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 200901530 | ⤷ Start Trial |
| South Africa | 200901592 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2008028956 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2008028957 | ⤷ Start Trial |
| United States of America | 2010034850 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
